Search Results - "Vergaro, G."

Cardiogenic shock and acute kidney injury: the rule rather than the exception by Ghionzoli, N, Sciaccaluga, C, Mandoli, GE, Vergaro, G, Gentile, F, D’Ascenzi, F, Mondillo, S, Emdin, M, Valente, S, Cameli, M

“…Cardiogenic shock (CS) is a life-threatening condition of poor end-organ perfusion, caused by any cardiovascular disease resulting in a severe depression of…”
Get full text

Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging by Barison, A., Aquaro, G. D., Pugliese, N. R., Cappelli, F., Chiappino, S., Vergaro, G., Mirizzi, G., Todiere, G., Passino, C., Masci, P. G., Perfetto, F., Emdin, M.

“…Background Cardiac involvement in systemic amyloidosis is caused by the extracellular deposition of misfolded proteins, mainly immunoglobulin light chains (AL)…”
Get full text

Cardiac amyloidosis characterization by kinetic model fitting on [18F]florbetaben PET images by Santarelli, M.F., Genovesi, D., Scipioni, M., Positano, V., Favilli, B., Giorgetti, A., Vergaro, G., Landini, L., Emdin, M., Marzullo, P.

“…To evaluate the feasibility of kinetic modeling-based approaches from [18F]-Flobetaben dynamic PET images as a non-invasive diagnostic method for cardiac…”
Get full text

The role of non-invasive imaging modalities in cardiac allograft vasculopathy: an updated focus on current evidences by Sciaccaluga, C, Ghionzoli, N, Mandoli, GE, Sisti, N, D’Ascenzi, F, Focardi, M, Bernazzali, S, Vergaro, G, Emdin, M, Valente, S, Cameli, M

“…Cardiac allograft vasculopathy (CAV) is an obliterative and diffuse form of vasculopathy affecting almost 50% of patients after 10 years from heart transplant…”
Get full text

CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy by Paoletti Perini, Alessandro, Bartolini, Simone, Pieragnoli, Paolo, Ricciardi, Giuseppe, Perrotta, Laura, Valleggi, Alessandro, Vergaro, Giuseppe, Michelotti, Federica, Boggian, Giulio, Sassone, Biagio, Mascioli, Giosuè, Emdin, Michele, Padeletti, Luigi

“…CHADS2 and CHA2DS2-VASc scores are pivotal in assessing the risk of stroke in atrial fibrillation patients, and were recently proved to predict…”
Get full text

Modern diagnostic and therapeutical approach to cardiac AL amyloidosis and neuroendocrine model of heart failure: lessons from a clinical case by Giannoni, A., Passino, C., Vergaro, G., Valleggi, A., Pastormerlo, L.E., Fontana, M., Poletti, R., Mammini, C., Aquaro, G., Benedetti, E., Petrini, M., Emdin, M.

Get full text

Cardiac sympathetic denervation in wild-type transthyretin amyloidosis by Aimo, A, Gimelli, A, Vergaro, G, Genovesi, D, Kusch, A, Emdin, M, Marzullo, P

“…Abstract Background Tissue accumulation of misfolded transthyretin (TTR) may occur because of TTR gene mutations (variant amyloid TTR amyloidosis, ATTRv), or…”
Get full text

Sacubitril/valsartan improves ventilation stability in patients with chronic heart failure by Sciarrone, P, Borrelli, C, Giannoni, A, Gentile, F, Aimo, A, Vergaro, G, Emdin, M, Passino, C

“…Abstract Background Sacubitril/valsartan (SV) ameliorates symptoms and prognosis in patients with heart failure and reduced ejection fraction (HFrEF), but the…”
Get full text

Incidence and clinical characteristics of cardiac amyloidosis in Tuscany and Umbria by Castiglione, V, Chubuchna, O, Mandoli, G E, Ferrari Chen, Y F, Aimo, A, Milli, M, Palazzuoli, A, Carluccio, E, Zuchi, C, Di Mario, C, Ambrosio, G, Cappelli, F, Emdin, M, Cameli, M, Vergaro, G

“…Abstract Background Recent advances in imaging and increased disease awareness have led to a significant rise in newly diagnosed cases of cardiac amyloidosis…”
Get full text

Cardiac involvement in creatine deficiency syndrome by Del Franco, A, Battini, R, Kusmic, C, Forini, F S, L'Abbate, S, Masotti, S, Musetti, V, Borrelli, C, Barison, A, Emdin, M, Vergaro, G

“…Abstract Background Previous reports have demonstrated electrocardiographic and echocardiographic abnormalities consistent with early-stage cardiomyopathy in…”
Get full text

Therapies for cardiac light chain amyloidosis: An update by Aimo, Alberto, Buda, Gabriele, Fontana, Marianna, Barison, Andrea, Vergaro, Giuseppe, Emdin, Michele, Merlini, Giampaolo

“…Light-chain (AL) amyloidosis is the most common type of systemic amyloidosis, affecting around 10 people per million per year. This serious disorder is…”
Get full text

Assessment of repolarization dispersion by using endocardial unipolar electrograms in patients with brugada syndrome and spontaneous coved-type electrocardiographic pattern by Latrofa, S, Garibaldi, S, Hartwig, V, Panchetti, L, Morelli, M S, Bachi, L, Nesti, M, Barison, A, Vergaro, G, Mirizzi, G, Startari, U, Passino, C, Emdin, M, Giannoni, A, Rossi, A

“…Abstract Background Coved-type electrocardiographic (ECG) pattern of patients with Brugada syndrome (BrS) is secondary to action potential lengthening in the…”
Get full text

Reverse remodelling, changes in diastolic function and their prognostic value compared to natriuretic peptides by Aimo, A, Vergaro, G, Fabiani, I, Chubuchny, V, Taddei, C, Giannoni, A, Arzilli, C, Passino, C, Emdin, M

“…Abstract Background Reverse remodelling (RR) is the recovery from left ventricular (LV) dilation and dysfunction in response to treatment for heart failure…”
Get full text

C61 RAREFACTION OF MYOCARDIAL LYMPHATIC VESSELS IN PATIENTS WITH CARDIAC AMYLOIDOSIS by Aimo, A, Martinelli, G, Bonino, L, Musetti, V, Castiglione, V, Emdin, M, Vergaro, G, Pucci, A

“…Abstract Introduction In cardiac amyloidosis (CA), amyloid fibers accumulate in the extracellular spaces of the heart, causing a compression and obliteration…”
Get full text

P203 PLASMA TRANSTHYRETIN FORMS IN PATIENTS WITH WILD–TYPE TRANSTHYRETIN CARDIAC AMYLOIDOSIS: INFLUENCED OF TAFAMIDIS TREATMENT by Sanguinetti, C, Vergaro, G, Aimo, A, Castiglione, V, Caponi, L, Paolicchi, A, Emdin, M, Franzini, M

“…Abstract Introduction Transthyretin (TTR) is a plasma protein that transports thyroxin and retinol complexed to retinol–binding protein (RBP). TTR misfolding…”
Get full text

Discharge FGF23 levels predicts one year outcome in patients admitted with acute heart failure by Aimo, A, Vergaro, G, Taurino, E, Del Franco, A, Fabiani, I, Prontera, C, Masotti, S, Musetti, V, Emdin, M, Passino, C

“…Abstract Background Patients with acute heart failure (AHF) show high levels of fibroblast growth factor-23 (FGF23) on admission. We examined if plasma FGF23…”
Get full text

Prevalence of amyloid transthyretin cardiomyopathy in elderly subjects from the general population: first results from the CATCH study by Aimo, A, Vergaro, G, Moscardini, S, Puccianti, D, Castiglione, V, Gentile, F, Fabiani, I, Barison, A, Agazio, A, Picerni, A, Poggianti, E, Taddei, C, Arzilli, C, Passino, C, Emdin, M

“…Abstract Background Amyloid transthyretin cardiomyopathy (ATTR-CM) has become treatable. Wild-type ATTR-CM is an age-related disorder. Establishing the exact…”
Get full text

Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis by Tomasoni, D, Aimo, A, Merlo, M, Nardi, M, Adamo, M, Cani, D, Lombardi, C M, Pancaldi, E, Panichella, G, Porcari, A, Vergaro, G, Sinagra, G, Rapezzi, C, Emdin, M, Metra, M

“…Abstract Aims The HFA-PEFF and H2FPEF scores have been developed to diagnose heart failure with preserved ejection fraction (HFpEF), and hold prognostic value…”
Get full text

Valve disease in cardiac amyloidosis: an echocardiographic score by Aimo, A, Fabiani, I, Maccarana, A, Vergaro, G, Chubuchny, V, Pasanisi, E M, Petersen, C, Poggianti, E, Giannoni, A, Spini, V, Taddei, C, Castiglione, V, Passino, C, Fontana, M, Emdin, M

“…Abstract Background Cardiac amyloidosis (CA) may affect all cardiac structures, including the valves. Methods From 423 patients undergoing a diagnostic workup…”
Get full text

P292 REDEFINING THE EPIDEMIOLOGY OF CARDIAC AMYLOIDOSIS. A SYSTEMATIC REVIEW OF SCREENING STUDIES by Aimo, A, Merlo, M, Porcari, A, Pagura, L, Sinagra, G, Vergaro, G, Emdin, M, Rapezzi, C

“…Abstract Background Over the last years, an algorithm for non–invasive diagnosis of amyloid transthyretin cardiac amyloidosis (ATTR–CA) and novel…”
Get full text